Skip to main content

stock

LBRX · LB PHARMACEUTICALS INC

What LB PHARMACEUTICALS INC reports to the SEC, read from its filings.

Open in the app

Price

The live LBRX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on LBRX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
32,259,175 as of 2026-08-05 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-25.8%
ROA
-23.7%

Health

Current ratio
15.1x
Debt/equity
—

Deep value

NCAV
$325.96M
NCAV per share
$10.10
Price/NCAV
Locked
NNWC
$253.77M
NNWC per share
$7.87
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating income (not reported by this company)Net incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$51.60M
10-Q filed 2026-08-11
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$19.05M
10-Q filed 2026-08-11
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$11.47M
10-K filed 2026-03-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$3.56M
10-Q filed 2025-11-06
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$4.87M
10-Q filed 2026-08-11
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$5.31M
10-Q filed 2026-08-11
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$5.07M
10-K filed 2026-03-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—Operating income: unreported by this company.-$14.18M
10-Q filed 2025-11-06
Assets
$361.69M
Equity
$332.35M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31——-$25.20M-$35.26M
2024-12-31——-$63.10M-$53.82M

Company filings

since Thu Oct 1 · 9 offering filings in 12 months

events

  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Sep 158-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Sep 38-K
  • Results

    Results
    Aug 118-K
  • Material agreement, Unregistered share sale, Regulation FD disclosure

    Material agreementUnregistered share saleRegulation FD disclosure
    Jul 298-K
  • Other event

    Other event
    Jul 228-K
  • Executive or director change

    Executive or director change
    Jun 108-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named LBRX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about LBRX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about LBRX.

nakagai

Signals on LBRX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the LBRX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

LB PHARMACEUTICALS INC (LBRX): SEC filings, financials and insider trades · Nakagai